The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Hypoxia downregulates the expression of activating receptors involved in NK‐cell‐mediated target cell killing without affecting ADCC
Open accessAbstract
In certain infection sites or tumor tissues, the disruption of homeostasis can give rise to a hypoxic microenvironment, which, in turn, can alter the function of different immune cell types and favor the progression of the disease. Natural killer (NK) cells are directly involved in the elimination of virus‐infected or transformed cells, however it is unknown whether their function is affected by hypoxia or not. In this study, we show that NK cells adapt to a hypoxic environment by upregulating the hypoxia‐inducible factor 1α. However, NK cells lose their ability to upregulate the surface expression of the major activating NK‐cell receptors (NK p46, NK p30, NK p44, and NKG 2 D) in response to IL‐2 (or other activating cytokines, including IL‐15, IL‐12, and IL‐21). These altered phenotypic features correlate with reduced responses to triggering signals resulting in impaired capability of killing infected or tumor target cells. Remarkably, hypoxia does not significantly alter the surface density and the triggering function of the F c‐γ receptor CD 16, thus allowing NK cells to maintain their capability of killing target cells via antibody‐dependent cellular cytotoxicity. This finding offers an important clue for exploitation of NK cell in antibody‐based immunotherapy of cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hypoxia — a key regulatory factor in tumour growth
Harris, A. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc704 · Cited by 5,177
Innate or adaptive immunity? The example of natural killer cells
Vivier, E., Raulet, D. H., Moretta, A., Caligiuri, M. A., Zitvogel, L., Lanier, L. L., Yokoyama, W. M., & Ugolini, S. (2011) · Science · doi:10.1126/science.1198687 · Cited by 2,824
HIF-1α is essential for myeloid cell-mediated inflammation
Cramer, T., Yamanishi, Y., Clausen, B. E., Förster, I., Pawlinski, R., Mackman, N., Haase, V. H., Jaenisch, R., Corr, M., Nizet, V., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00154-5 · Cited by 2,046
Caligiuri, M. A. (2008) · Blood · doi:10.1182/blood-2007-09-077438 · Cited by 1,905
Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation
Groh, V., Wu, J., Yee, C., & Spies, T. (2002) · Nature · doi:10.1038/nature01112 · Cited by 1,592
Oxygen Sensing, Homeostasis, and Disease
Semenza, G. L. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1011165 · Cited by 993
Bryceson, Y. T., March, M. E., Ljunggren, H.-G., & Long, E. O. (2006) · Blood · doi:10.1182/blood-2005-04-1351 · Cited by 863
Castriconi, R., Cantoni, C., Della Chiesa, M., Vitale, M., Marcenaro, E., Conte, R., Biassoni, R., Bottino, C., Moretta, L., & Moretta, A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0730640100 · Cited by 726
Self-citationInterdependence of hypoxic and innate immune responses
Nizet, V., & Johnson, R. S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2607 · Cited by 708
NK cells and cancer immunosurveillance
Waldhauer, I., & Steinle, A. (2008) · Oncogene · doi:10.1038/onc.2008.267 · Cited by 682
Mamessier, E., Sylvain, A., Thibult, M.-L., Houvenaeghel, G., Jacquemier, J., Castellano, R., Gonçalves, A., André, P., Romagné, F., Thibault, G., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45816 · Cited by 681
Regulation of immune cells by local-tissue oxygen tension: HIF1α and adenosine receptors
Sitkovsky, M., & Lukashev, D. (2005) · Nature Reviews Immunology · doi:10.1038/nri1685 · Cited by 518
Profound Coordinated Alterations of Intratumoral NK Cell Phenotype and Function in Lung Carcinoma
Platonova, S., Cherfils-Vicini, J., Damotte, D., Crozet, L., Vieillard, V., Validire, P., André, P., Dieu-Nosjean, M.-C., Alifano, M., Régnard, J.-F., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4179 · Cited by 512
Hypoxia-responsive transcription factors
Cummins, E. P., & Taylor, C. T. (2005) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-005-1413-7 · Cited by 464
Mellor, J. D., Brown, M. P., Irving, H. R., Zalcberg, J. R., & Dobrovic, A. (2013) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-6-1 · Cited by 415
Macrophage Responses to Hypoxia
Lewis, C., & Murdoch, C. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62038-x · Cited by 413
Chiesa, M. D., Carlomagno, S., Frumento, G., Balsamo, M., Cantoni, C., Conte, R., Moretta, L., Moretta, A., & Vitale, M. (2006) · Blood · doi:10.1182/blood-2006-03-006700 · Cited by 399
Self-citationHypoxia-Inducible Factors as Essential Regulators of Inflammation
Imtiyaz, H. Z., & Simon, M. C. (2010) · Current Topics in Microbiology and Immunology · doi:10.1007/82_2010_74 · Cited by 379
Sceneay, J., Chow, M. T., Chen, A., Halse, H. M., Wong, C. S. F., Andrews, D. M., Sloan, E. K., Parker, B. S., Bowtell, D. D., Smyth, M. J., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3873 · Cited by 364
Lakshmikanth, T., Burke, S., Ali, T. H., Kimpfler, S., Ursini, F., Ruggeri, L., Capanni, M., Umansky, V., Paschen, A., Sucker, A., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36022 · Cited by 347
NK Cells Recognize and Kill Human Glioblastoma Cells with Stem Cell-Like Properties
Castriconi, R., Daga, A., Dondero, A., Zona, G., Poliani, P. L., Melotti, A., Griffero, F., Marubbi, D., Spaziante, R., Bellora, F., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802845 · Cited by 337
Self-citationMelanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity
Balsamo, M., Scordamaglia, F., Pietra, G., Manzini, C., Cantoni, C., Boitano, M., Queirolo, P., Vermi, W., Facchetti, F., Moretta, A., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906481106 · Cited by 330
Self-citationPietra, G., Manzini, C., Rivara, S., Vitale, M., Cantoni, C., Petretto, A., Balsamo, M., Conte, R., Benelli, R., Minghelli, S., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2544 · Cited by 324
Self-citationHalama, N., Braun, M., Kahlert, C., Spille, A., Quack, C., Rahbari, N., Koch, M., Weitz, J., Kloor, M., Zoernig, I., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2173 · Cited by 300
Natural killer cell–directed therapies: moving from unexpected results to successful strategies
Terme, M., Ullrich, E., Delahaye, N. F., Chaput, N., & Zitvogel, L. (2008) · Nature Immunology · doi:10.1038/ni1580 · Cited by 289
Development of HIF‐1 inhibitors for cancer therapy
Onnis, B., Rapisarda, A., & Melillo, G. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00876.x · Cited by 268
Hypoxia inducible factor (HIF) function in innate immunity and infection
Zinkernagel, A. S., Johnson, R. S., & Nizet, V. (2007) · Journal of Molecular Medicine · doi:10.1007/s00109-007-0282-2 · Cited by 265
Moretta, L., Locatelli, F., Pende, D., Marcenaro, E., Mingari, M. C., & Moretta, A. (2011) · Blood · doi:10.1182/blood-2010-08-264085 · Cited by 229
Self-citationMolecular pathways: hypoxia response in immune cells fighting or promoting cancer
Palazón, A., Aragonés, J., Morales-Kastresana, A., de Landázuri, M. O., & Melero, I. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1591 · Cited by 214
Natural killer cell‐based immunotherapy in cancer: current insights and future prospects
Sutlu, T., & Alici, E. (2009) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2009.02121.x · Cited by 200
Bosco, M. C., Puppo, M., Santangelo, C., Anfosso, L., Pfeffer, U., Fardin, P., Battaglia, F., & Varesio, L. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.3.1941 · Cited by 199
Self-citationRoiniotis, J., Dinh, H., Masendycz, P., Turner, A., Elsegood, C. L., Scholz, G. M., & Hamilton, J. A. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804216 · Cited by 167
Monocytes and dendritic cells in a hypoxic environment: Spotlights on chemotaxis and migration
Bosco, M. C., Puppo, M., Blengio, F., Fraone, T., Cappello, P., Giovarelli, M., & Varesio, L. (2008) · Immunobiology · doi:10.1016/j.imbio.2008.07.031 · Cited by 166
Self-citationEnhanced In Vivo Growth of Lymphoma Tumors in the Absence of the NK-Activating Receptor NKp46/NCR1
Halfteck, G. G., Elboim, M., Gur, C., Achdout, H., Ghadially, H., & Mandelboim, O. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0801878 · Cited by 162
Natural killer cells kill human melanoma cells with characteristics of cancer stem cells
Pietra, G., Manzini, C., Vitale, M., Balsamo, M. L., Ognio, E., Boitano, M., Queirolo, P., Moretta, L., & Mingari, M. C. (2009) · International Immunology · doi:10.1093/intimm/dxp047 · Cited by 158
Self-citationSun, J. C.-Y., Beilke, J. N., Bezman, N., & Lanier, L. L. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20100479 · Cited by 146
Altered phenotype in peripheral blood and tumor-associated NK cells from colorectal cancer patients
Rocca, Y., Roberti, M. P., Arriaga, J. M., Amat, M., Bruno, L. I., Pampena, M. B., Huertas, E., Loria, F. S., Pairola, A., Bianchini, M., et al. (2012) · Innate Immunity · doi:10.1177/1753425912453187 · Cited by 144
Natural Killer Cells and Solid Tumors
Stojanovic, A., & Cerwenka, A. (2011) · Journal of Innate Immunity · doi:10.1159/000325465 · Cited by 137
Bosco, M. C., Pierobon, D., Blengio, F., Raggi, F., Vanni, C., Gattorno, M., Eva, A., Novelli, F., Cappello, P., Giovarelli, M., et al. (2010) · Blood · doi:10.1182/blood-2010-06-292136 · Cited by 129
Self-citationMagri, G., Muntasell, A., Romo, N., Sáez‐Borderías, A., Pende, D., Geraghty, D. E., Hengel, H., Angulo, A., Moretta, A., & López‐Botet, M. (2010) · Blood · doi:10.1182/blood-2010-08-301374 · Cited by 122
Pahl, J. H. W., Ruslan, S. E. N., Buddingh, E. P., Santos, S. J., Szuhai, K., Serra, M., Gelderblom, H. A. J., Hogendoorn, P. C. W., Egeler, R. M., Schilham, M. W., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2277 · Cited by 121
Balsamo, M., Vermi, W., Parodi, M., Pietra, G., Manzini, C., Queirolo, P., Lonardi, S., Augugliaro, R., Moretta, A., Facchetti, F., et al. (2012) · European Journal of Immunology · doi:10.1002/eji.201142179 · Cited by 110
Self-citationWood, S. M., Meeths, M., Chiang, S. C. C., Bechensteen, A. G., Boelens, J. J., Heilmann, C. J., Horiuchi, H., Rosthøj, S., Rutynowska‐Pronicka, O., Winiarski, J. H., et al. (2009) · Blood · doi:10.1182/blood-2009-06-225359 · Cited by 106
Fardin, P., Barla, A., Mosci, S., Rosasco, L., Verri, A., Versteeg, R., Caron, H. N., Molenaar, J. J., Øra, I., Eva, A., et al. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-185 · Cited by 102
Self-citationLearning how to discriminate between friends and enemies, a lesson from Natural Killer cells
Bottino, C., Moretta, L., Pende, D., Vitale, M., & Moretta, A. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2004.04.004 · Cited by 88
Self-citationMacrophages and the hypoxic tumour microenvironment
Knowles, H. J. (2007) · Frontiers in bioscience · doi:10.2741/2389 · Cited by 77
Puppo, M., Battaglia, F., Ottaviano, C., Delfino, S., Ribatti, D., Varesio, L., & Bosco, M. C. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-2059 · Cited by 74
Self-citationHypoxia: a double-edged sword of immunity
Sica, A., Melillo, G., & Varesio, L. (2011) · Journal of Molecular Medicine · doi:10.1007/s00109-011-0724-8 · Cited by 66
Self-citationFink, T., Ebbesen, P., Koppelhus, U., & Zachar, V. (2003) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2003.01347.x · Cited by 60
Sun, J., Zhang, Y., Yang, M., Zhang, Y., Xie, Q., Li, Z., Dong, Z., Yang, Y., Deng, B., Feng, A., et al. (2009) · Cellular and Molecular Immunology · doi:10.1038/cmi.2009.105 · Cited by 58
Dendritic cell reprogramming by the hypoxic environment
Bosco, M. C., & Varesio, L. (2012) · Immunobiology · doi:10.1016/j.imbio.2012.07.023 · Cited by 39
Self-citationVeeranna, R. P., Haque, M., Davis, D. A., Yang, M., & Yarchoan, R. (2011) · Journal of Virology · doi:10.1128/jvi.05167-11 · Cited by 37
NK Cells and their Receptors during Viral Infections
Marcenaro, E., Carlomagno, S., Pesce, S., Chiesa, M. D., Parolini, S., Moretta, A., & Sivori, S. (2011) · Immunotherapy · doi:10.2217/imt.11.99 · Cited by 29
Hypoxia inhibits Moloney murine leukemia virus expression in activated macrophages
Puppo, M., Bosco, M. C., Federico, M., Pastorino, S., & Varesio, L. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0506361 · Cited by 10
Self-citation
Cited by
Metabolism of immune cells in cancer
Leone, R. D., & Powell, J. D. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-020-0273-y · Cited by 877
Natural killer cells in cancer biology and therapy
Wu, S.-Y., Fu, T., Jiang, Y.-Z., & Shao, Z.-M. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01238-x · Cited by 863
NK Cell Metabolism and Tumor Microenvironment
Terrén, I., Orrantia, A., Vitallé, J., Zenarruzabeitia, O., & Borrego, F. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02278 · Cited by 501
Influence of the Tumor Microenvironment on NK Cell Function in Solid Tumors
Melaiu, O., Lucarini, V., Cifaldi, L., & Fruci, D. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.03038 · Cited by 419
Effect of tumor cells and tumor microenvironment on NK‐cell function
Vitale, M., Cantoni, C., Pietra, G., Mingari, M. C., & Moretta, L. (2014) · European Journal of Immunology · doi:10.1002/eji.201344272 · Cited by 412
Self-citation
Metadata
- Authors
- Balsamo, M., Manzini, C., Pietra, G., Raggi, F., Blengio, F., Mingari, M. C., Varesio, L., Moretta, L., Bosco, M. C., & Vitale, M.
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 2013-08-05
- Volume
- 43
- Issue
- 10
- Pages
- 2756-2764
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- OpenAlex
- W1594965720
- Cited by
- 282
- References
- 54
- FWCI
- 4.88
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.